Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anthony Stell has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Higher HbA1c Following Younger Age of Transfer From Pediatric to Adult Type 1 Diabetes Services: Data From the Australasian Diabetes Data Network (ADDN) Registry

    by Steven James, Kim C. Donaghue, Jennifer J. Couper, Peter G. Colman, Lin Perry, Julia Lowe, Dianna J. Magliano, Olive James, Robin Wan, Anthony Stell, et al.

    OBJECTIVE: To determine outcomes from early versus later age of transfer from pediatric to adult type 1 diabetes (T1D) services, and factors associated with adult service HbA1c. RESEARCH DESIGN AND METHODS: We used a longitudinal design from the Australasian Diabetes Data Network (ADDN) registry. Transferred youth (2013–2022) were compared by age group at last pediatric visit (<18 vs. ≥18 years). Multivariable generalized estimated equations (GEEs) were used to model factors associated with adult-service HbA1c. Explanatory variables included transfer age, sex, socioeconomic status, and mean HbA1c in the 36 months before transfer. RESULTS: There were 784 youth (n = 342 early and 442 late transferers; 49.7% male). The mean ± SD transfer age was 18.1 ± 1.4 years with median [interquartile range] 18.2 [5.5; 38.9] months of adult-service follow-up. The gap between the last pediatric and first adult visit was longer in early transferers (13.5 [5.5; 28.0] vs. 8.1 [3.7; 23.8] months; P < 0.001). At first adult visit, early transferers had higher HbA1c (9.3 ± 1.9 vs. 8.8 ± 1.9% [78.2 ± 20.6 vs. 72.9 ± 20.4 mmol/mol]; P = 0.01) and socioeconomic disadvantage (score 976.8 ± 101.7 vs. 992.8 ± 81.1; P = 0.03). In multivariable GEEs, higher adult-service HbA1c was associated with younger transfer age (β = −0.15; 95% CI −0.30 to −0.002; P = 0.047), socioeconomic disadvantage (β = 0.58; 95% CI 0.10–1.06; P = 0.02), and higher mean HbA1c in the 36 months before transfer (β = 0.06; 95% CI 0.04–0.07; P < 0.001). CONCLUSIONS: Early transfer from pediatric to adult T1D services was associated with higher HbA1c in real-world settings. There is a need for caution with early transfer. Findings should be interpreted in the context of other international models to understand optimal transfer timing.

  • A Platform for the Delivery of Speech Treatment for Dysarthria in Multisystemic Ataxia

    by Anthony Stell, Adam P. Vogel, Jean Paul Vera Soto, Alejandra Abril Pareja, Richard Sinnott

    Hereditary ataxias can lead to impaired speech, which can cause social isolation, and ability to complete daily tasks. A recently developed therapeutic intervention for dysarthria (a neuromuscular speech disorder)- is a therapy program of vocal exercises designed by speech pathologists. Due to the need for intensive and sustained practice of these exercises, combined with the requirement of clinical oversight, a novel method of delivery is required. The delivery must allow patients to perform these exercises in a systematic way, provide feedback to their supporting clinician in a timely manner, and be provided with graphical feedback of their progress in realtime both during the exercises and over the longer term. The SpeechATTAX project has developed a tablet-based application that supports all of these requirements through novel audiovisual biofeedback, notifications, and text information tailored to the patient's condition and the stage of progress in their therapy. This paper presents the system architecture of the application, conceptual challenges and solutions, and shows how the platform supports qualitative feedback from a representative population.

  • Open Access

    Deep Learning Approaches Applied to Image Classification of Renal Tumors: A Systematic Review

    by Sandra Amador, Felix Beuschlein, Vedant Chauhan, Judith Favier, David Gil, Phillip Greenwood, R. R. de Krijger, Matthias Kroiss, Samanta Ortuño-Miquel, Attila Patocs, et al.

    Renal cancer is one of the ten most common cancers in the population that affects 65,000 new patients a year. Nowadays, to predict pathologies or classify tumors, deep learning (DL) methods are effective in addition to extracting high-performance features and dealing with segmentation tasks. This review has focused on the different studies related to the application of DL techniques for the detection or segmentation of renal tumors in patients. From the bibliographic search carried out, a total of 33 records were identified in Scopus, PubMed and Web of Science. The results derived from the systematic review give a detailed description of the research objectives, the types of images used for analysis, the data sets used, whether the database used is public or private, and the number of patients involved in the studies. The first paper where DL is applied compared to other types of tumors was in 2019 which is relatively recent. Public collection and sharing of data sets are of utmost importance to increase research in this field as many studies use private databases. We can conclude that future research will identify many benefits, such as unnecessary incisions for patients and more accurate diagnoses. As research in this field grows, the amount of open data is expected to increase.


  • Open Access

    A GDPR-Compliant Dynamic Consent Mobile Application for the Australasian Type-1 Diabetes Data Network

    by Zhe Wang, Anthony Stell, Richard O. Sinnott, the ADDN Study Group

    Australia has a high prevalence of diabetes, with approximately 1.2 million Australians diagnosed with the disease. In 2012, the Australasian Diabetes Data Network (ADDN) was established with funding from the Juvenile Diabetes Research Foundation (JDRF). ADDN is a national diabetes registry which captures longitudinal information about patients with type-1 diabetes (T1D). Currently, the ADDN data are directly contributed from 42 paediatric and 17 adult diabetes centres across Australia and New Zealand, i.e., where the data are pre-existing in hospital systems and not manually entered into ADDN. The historical data in ADDN have been de-identified, and patients are initially afforded the opportunity to opt-out of being involved in the registry; however, moving forward, there is an increased demand from the clinical research community to utilise fully identifying data. This raises additional demands on the registry in terms of security, privacy, and the nature of patient consent. General Data Protection Regulation (GDPR) is an increasingly important mechanism allowing individuals to have the right to know about their health data and what those data are being used for. This paper presents a mobile application being designed to support the ADDN data collection and usage processes and aligning them with GDPR. The app utilises Dynamic Consent—an informed specific consent model, which allows participants to view and modify their research-driven consent decisions through an interactive interface. It focuses specifically on supporting dynamic opt-in consent to both the registry and to associated sub-projects requesting access to and use of the patient data for research purposes.


  • Secure Audit in Support of an Adrenal Cancer Registry

    by Anthony Stell, Vedant Chauhan, Richard Sinnott

  • Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours

    by Yaxin An, Manja Reimann, Jimmy Masjkur, Katharina Langton, Mirko Peitzsch, Timo Deutschbein, Martin Fassnacht, Natalie Rogowski-Lehmann, Felix Beuschlein, Stephanie Fliedner, et al.

    Obesity-associated activation of sympathetic nervous outflow is well documented, whereas involvement of dysregulated adrenomedullary hormonal function in obesity is less clear. This study assessed relationships of sympathoadrenal function with indices of obesity and influences of circulating catecholamines on body mass. Anthropometric and clinical data along with plasma and 24-h urine samples were collected from 590 volunteers and 1368 patients tested for phaeochromocytoma and paraganglioma (PPGL), among whom tumours were diagnosed in 210 individuals. Among patients tested for PPGL, those with tumours less often had a body mass index (BMI) above 30 kg/m2 (12 vs. 31%) and more often a BMI under 25 kg/m2 (56 vs. 32%) than those without tumours (P < 0.0001). Urinary outputs of catecholamines in patients with PPGL were negatively related to BMI (r = −0.175, P = 0.0133). Post-operative weight gain (P < 0.0001) after resection of PPGL was positively related to presurgical tumoural catecholamine output (r = 0.257, P = 0.0101). Higher BMI in men and women and percent body fat in women of the volunteer group were associated with lower plasma concentrations and urinary outputs of adrenaline and metanephrine, the former indicating obesity-related reduced adrenaline secretion and the latter obesity-related reduced adrenomedullary adrenaline stores. Daytime activity was associated with substantial increases in urinary adrenaline and noradrenaline excretion, with blunted responses in obese subjects. The findings in patients with PPGL support an influence of high circulating catecholamines on body weight. Additional associations of adrenomedullary dysfunction with obesity raise the possibility of a permissive influence of the adrenal medulla on the regulation of body weight.


  • e-Enabling International Cancer Research: Lessons Being Learnt in the ENS@T-CANCER Project

    by Anthony Stell, Richard Sinnott

    Breakthroughs in biomedicine are driven by research. More often than not, research takes place outside of a healthcare setting. However access to and use of clinical data for research purposes has many challenges that must be overcome, not least of which are the lack of standardized nomenclature and the heterogeneity of healthcare IT systems. For rare conditions, this challenge is particularly acute since the scarcity of data makes scientific breakthroughs increasingly difficult. Adrenal tumours represent one rare disease area where consolidation of clinical and biological information is urgently required. This paper describes the lessons being learnt in the development and rollout of an advanced security-oriented, virtual research environment (VRE) as part of the EU funded ENS@T-CANCER project. This system is currently used by 39 major cancer research centres across Europe and provides a unique resource for adrenal cancer research, underpinning an expanding portfolio of major international clinical trials and studies.


  • Open Access

    Dynamic trust negotiation for flexible e-health collaborations

    by Oluwafemi Ajayi, Richard Sinnott, Anthony Stell

    © ACM, 2008. This is the author's version of the work. It is posted here by permission of ACM for your personal use. Not for redistribution. The definitive version was published in Proceedings of the 15th ACM Mardi Gras conference: From lightweight mash-ups to lambda grids: Understanding the spectrum of distributed computing requirements, applications, tools, infrastructures, interoperability, and the incremental adoption of key capabilities, 320, (2008) http://doi.acm.org/10.1145/1341811.1341821Security issues have always limited the way we do things. In an organisation we provide security by granting privileges to either identities or roles. However this becomes more challenging when the objective is collaboration across organisational boundaries. Numerous access control approaches exist today to address the cross-boundary control issues. However an optimal approach would be to fold remote security credentials into local security credentials, thereby bridging the gap that makes decentralised security policies for multi-domain collaboration difficult. In this paper, dynamic trust negotiation is presented as a possible optimal approach that provides support for decentralised access control. We show how trust pathways can be established and how remote security credentials could be folded to local security credentials through trust contracts.January 29-February 3Open Acces